UCSF Adult Inpatient Susceptibility Data (Gram-Positives)1
R-testing not applicable to organism and should be considered resistant, AMP-ampicillin, CLIN-clindamycin, CTRX-ceftriaxone, DAP-daptomycin, DOX-doxycycline, LZD-linezolid, NAF-nafcillin, PCN-penicillin G, T/S-trimethoprim/sulfamethoxazole, VANC-vancomycin
Total isolates include floor isolates and ICU isolates from Parnassus, MB Adult, and MZ
Reported as % susceptible, tested from all sites except as indicated
|
Organism |
Total Isolates |
AMP/PCN2 |
CLIN |
CTRX |
DAP |
DOX |
LZD |
NAF |
T/S |
VANC |
|---|---|---|---|---|---|---|---|---|---|---|
|
Staphylococcus aureus |
833 |
N/A |
73 |
N/A |
100 |
88 |
100 |
72 |
96 |
100 |
|
MSSA |
609 |
N/A |
77 |
N/A |
100 |
93 |
100 |
99 |
97 |
100 |
|
MRSA |
234 |
N/A |
62 |
N/A |
100 |
72 |
100 |
N/A |
94 |
99 |
|
Staphylococcus epidermidis |
252 |
N/A |
56 |
N/A |
100 |
77 |
100 |
29 |
51 |
100 |
|
Staphylococcus lugdunesis |
36 |
N/A |
83 |
N/A |
100 |
88 |
100 |
80 |
51 |
100 |
|
Viridans group streptococci3 |
87 |
79 |
84 |
95 |
|
61 |
|
|
|
100 |
|
Streptococcus mitis |
44 |
72 |
84 |
97 |
|
70 |
|
|
|
100 |
|
Enterococcus faecalis |
281 |
99 |
N/A |
N/A |
100 |
27 |
100 |
N/A |
N/A |
97 |
|
Enterococcus faecium |
169 |
14 |
N/A |
N/A |
984 |
36 |
96 |
N/A |
N/A |
41 |
1Adult inpatient susceptibilities include data from 4/1/2023-3/31/2024; 2Reflects ampicillin for Enterococcus spp & penicillin G for Streptococcus spp; 3Viridans group streptococci include S. anginosus, S. constellatus, S. intermedius, S. milleri, S. mitis, S. mutans, S. oralis, S. parasanguinis, S. salivarius, & S. sobrinus; 4Represents susceptible dose-dependent isolates only